Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Neuroendocrine influences on cancer biology.

Thaker PH, Sood AK.

Semin Cancer Biol. 2008 Jun;18(3):164-70. doi: 10.1016/j.semcancer.2007.12.005. Epub 2007 Dec 8. Review.

2.

The neuroendocrine impact of chronic stress on cancer.

Thaker PH, Lutgendorf SK, Sood AK.

Cell Cycle. 2007 Feb 15;6(4):430-3. Epub 2007 Feb 9. Review.

PMID:
17312398
3.

Neuroendocrine influences on cancer progression.

Armaiz-Pena GN, Cole SW, Lutgendorf SK, Sood AK.

Brain Behav Immun. 2013 Mar;30 Suppl:S19-25. doi: 10.1016/j.bbi.2012.06.005. Epub 2012 Jun 21. Review.

4.

Neuroendocrine modulation of cancer progression.

Armaiz-Pena GN, Lutgendorf SK, Cole SW, Sood AK.

Brain Behav Immun. 2009 Jan;23(1):10-5. doi: 10.1016/j.bbi.2008.06.007. Epub 2008 Jun 27. Review.

5.

Tumor dormancy and the neuroendocrine system: an undisclosed connection?

ZappalĂ  G, McDonald PG, Cole SW.

Cancer Metastasis Rev. 2013 Jun;32(1-2):189-200. doi: 10.1007/s10555-012-9400-x. Review.

PMID:
23090259
6.

Impact of stress on cancer metastasis.

Moreno-Smith M, Lutgendorf SK, Sood AK.

Future Oncol. 2010 Dec;6(12):1863-81. doi: 10.2217/fon.10.142. Review.

7.

Wound healing and local neuroendocrine regulation in the injured liver.

Ebrahimkhani MR, Elsharkawy AM, Mann DA.

Expert Rev Mol Med. 2008 Apr 29;10:e11. doi: 10.1017/S146239940800063X. Review.

PMID:
18442446
8.

Prostanoid receptor signaling relevant to tumor growth and angiogenesis.

Majima M, Amano H, Hayashi I.

Trends Pharmacol Sci. 2003 Oct;24(10):524-9. Review. No abstract available.

PMID:
14559404
9.

Tissue Factor: Old and New Links with Cancer Biology.

Versteeg HH.

Semin Thromb Hemost. 2015 Oct;41(7):747-55. doi: 10.1055/s-0035-1556048. Epub 2015 Sep 26. Review.

PMID:
26408927
10.

The effects of insulin and insulin-like growth factors on tumor vascularization: new insights of insulin-like growth factor family in cancer.

Orciari S, Di Nuzzo S, Lazzarini R, Caprari P, Procopio A, Catalano A.

Curr Med Chem. 2009;16(30):3931-42. Review.

PMID:
19747131
11.

The influence of bio-behavioural factors on tumour biology: pathways and mechanisms.

Antoni MH, Lutgendorf SK, Cole SW, Dhabhar FS, Sephton SE, McDonald PG, Stefanek M, Sood AK.

Nat Rev Cancer. 2006 Mar;6(3):240-8. Review.

12.

The biology of integrins.

Stupack DG.

Oncology (Williston Park). 2007 Aug;21(9 Suppl 3):6-12. Review.

13.

Semaphorin signaling in vascular and tumor biology.

Neufeld G, Lange T, Varshavsky A, Kessler O.

Adv Exp Med Biol. 2007;600:118-31. Review.

PMID:
17607951
14.

Mapping pathways from stress to cancer progression.

Ross K.

J Natl Cancer Inst. 2008 Jul 2;100(13):914-5, 917. doi: 10.1093/jnci/djn229. Epub 2008 Jun 24. No abstract available.

PMID:
18577741
15.

Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.

Miller AH, Ancoli-Israel S, Bower JE, Capuron L, Irwin MR.

J Clin Oncol. 2008 Feb 20;26(6):971-82. doi: 10.1200/JCO.2007.10.7805. Review.

16.

Molecular heterogeneity of tumor endothelium.

Aird WC.

Cell Tissue Res. 2009 Jan;335(1):271-81. doi: 10.1007/s00441-008-0672-y. Epub 2008 Aug 23.

PMID:
18726119
17.

CXCR7 in tumorigenesis and progression.

Hou KL, Hao MG, Bo JJ, Wang JH.

Chin J Cancer. 2010 Apr;29(4):456-9. Review.

18.

HIFs, angiogenesis, and cancer.

Yang Y, Sun M, Wang L, Jiao B.

J Cell Biochem. 2013 May;114(5):967-74. doi: 10.1002/jcb.24438. Review.

PMID:
23225225
19.

Consice review: Contribution of cancer stem cells to neovascularization.

Ping YF, Bian XW.

Stem Cells. 2011 Jun;29(6):888-94. doi: 10.1002/stem.650. Review.

20.

Modulating tumor vasculature through signaling inhibition to improve cytotoxic therapy.

Maity A, Bernhard EJ.

Cancer Res. 2010 Mar 15;70(6):2141-5. doi: 10.1158/0008-5472.CAN-09-3615. Epub 2010 Feb 23. Review.

Supplemental Content

Support Center